1-Deoxynojirimycin affects high glucose-induced pancreatic beta-cell dysfunction through regulating CEBPA expression and AMPK pathway
- 1 January 2025
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 103, 1-12
Abstract
This study aims to explore the role of 1-deoxynojirimycin (DNJ) in high glucose-induced β-cells and to further explore the molecular mechanism of DNJ effect on β-cells through network pharmacology. In the study, high glucose treatment of mouse INS-1 cells inhibited cell proliferation and insulin secretion, decreased the expression of Bcl-2 protein and Ins1 and Ins2 genes, promoted apoptosis, and increased cleaved caspase-3 and cleaved caspase-9 expression levels as well as intracellular reactive oxygen species production. DNJ treatment significantly restored the dysfunction of INS-1 cells induced by high glucose, and DNJ showed no toxicity to normal INS-1 cells. Silencing CEBPA promoted, while overexpression of CEBPA relieved the dysfunction of pancreatic β-cells induced by high glucose. DNJ treatment partially restored the pancreatic β-cell dysfunction caused by silencing CEBPA. In conclusion, DNJ can inhibit high glucose-induced pancreatic β-cell dysfunction by promoting the expression of CEBPA.Keywords
Funding Information
- Science and Technology Planning Project of Guizhou Province in China
- Hunan Provincial Department of Education (21C0634)
- Foundation of Hunan Double First-rate Discipline Construction Projects of Bioengineering and Science
This publication has 42 references indexed in Scilit:
- Type 1 diabetes mellitus: Inflammation, mitophagy, and mitochondrial functionMitochondrion, 2023
- 1-Deoxynojirimycin attenuates septic cardiomyopathy by regulating oxidative stress, apoptosis, and inflammation via the JAK2/STAT6 signaling pathwayBiomedicine & Pharmacotherapy, 2022
- Effect of 1-Deoxynojirimycin on insulin resistance in prediabetic mice based on next-generation sequencing and intestinal microbiota studyJournal of Ethnopharmacology, 2022
- miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafFMolecular Therapy Nucleic Acids, 2021
- Protective and therapeutic effects of natural products against diabetes mellitus via regenerating pancreaticβ‐cells and restoring their dysfunctionPhytotherapy Research, 2020
- Asprosin promotes β‐cell apoptosis by inhibiting the autophagy of β‐cell via AMPK‐mTOR pathwayJournal of Cellular Physiology, 2020
- Alpha-glucosidase inhibitor 1-Deoxynojirimycin promotes beige remodeling of 3T3-L1 preadipocytes via activating AMPKBiochemical and Biophysical Research Communications, 2019
- Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential interventionDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
- Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes MellitusJACC, 2018
- 1-Deoxynojirimycin attenuates high glucose-accelerated senescence in human umbilical vein endothelial cellsExperimental Gerontology, 2014